Nutex Health is trading 6.00% lower at $182.02 after its November 5 earnings release, with year-over-year declines in revenue and profit. - Revenue beat estimates but fell 18.7% year over year to $217.6 million. - Diluted EPS fell to $5.71 from $7.76, and attributable net income declined to $40.2 million from $55.4 million. - Hospital visit volumes strengthened, and EPS beat one estimate; sector context was negative while broad-market indices rose.